Carmell Closes $1.85M PIPE Investment to Support Commercial Build-out
DENVER, Colo., Dec 24, 2024 (247marketnews.com)- Carmell (NASDAQ: CTCX) entered into an agreement for the issuance and sale of 8,065,210 shares of its common stock and an equal number of five-year warrants, both priced at $0.23 per share, in a private placement for aggregate gross proceeds of $1.85 million, less offering expenses and fees, and an additional $1.85 million in proceeds to Carmell if the warrants are exercised.
Rajiv Shukla, Chairman of Carmell, stated, “We are happy to announce an additional round of investment from existing and new investors to support the continued commercial build out of our revolutionary bio-aesthetics product pipeline.”
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Related news for (CTCX)
- CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY
- Carmell Announces Closing of Elevai Skincare Acquisition
- Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out
- 24/7 Market News Snapshot 02 January, 2025 – Carmell Corporation Common Stock (NASDAQ:CTCX)
- Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products